Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
0.195
-0.006 (-2.74%)
At close: Dec 20, 2024, 4:00 PM
0.202
+0.007 (3.54%)
After-hours: Dec 20, 2024, 7:52 PM EST

Bionano Genomics Revenue

Bionano Genomics had revenue of $6.07M in the quarter ending September 30, 2024, a decrease of -34.83%. This brings the company's revenue in the last twelve months to $33.33M, down -0.82% year-over-year. In the year 2023, Bionano Genomics had annual revenue of $36.12M with 29.90% growth.

Revenue (ttm)
$33.33M
Revenue Growth
-0.82%
P/S Ratio
0.36
Revenue / Employee
$96,901
Employees
344
Market Cap
19.89M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202336.12M8.31M29.90%
Dec 31, 202227.80M9.82M54.62%
Dec 31, 202117.98M9.48M111.47%
Dec 31, 20208.50M-1.63M-16.06%
Dec 31, 201910.13M-1.87M-15.59%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Equillium 45.91M
American Shared Hospital Services 24.97M
BioLineRx 21.99M
VSee Health 8.06M
Affimed 6.29M
Revenue Rankings